H7N9 flu peril lies in deep lung infiltration, study reports

July 3, 2013

The H7N9 bird flu virus is a peril for humans because it replicates deep in the lungs where it can trigger a dangerous response from the immune system, a study said Wednesday.

In addition, no one is likely to have pre-existing immunity to H7N9 and so-called seasonal vaccines cannot protect against it, the study said, confirming suspicions among many virologists.

And while show that leading anti- are effective, there are concerns the virus may acquire gene mutations to blunt these weapons, it added.

The study, published in Nature by the Chinese Centre for Disease Control and Prevention (CDC) in Beijing, delved into the genetic ID of the virus which emerged in China in February.

The virus has been characterised by severe symptoms of pneumonia and , with a high , especially among the elderly.

There have been 131 confirmed cases of H7N9 in China, with at least 40 fatalities, according to Chinese figures. An additional case of illness occurred in Taiwan, involving a man who had been working in China.

H7N9 has a shape of receptor, or docking point, that enables it to latch onto cells in the lining of the and replicate there, the investigators said.

In contrast, the virus is less able to replicate in the trachea than in the lungs, which may help explain why it is not easily transmissible through the traditional pathway of coughs and sneezes.

H7N9 worsens the illness by triggering an uncontrolled reaction from the immune system, the study suggested. This "cytokine storm" can cause inflammation, and fluid build-up in the lungs.

The researchers took from children aged between three and five; from adults aged 18 to 59; and seniors over 60 and exposed them to the virus.

The 90 samples showed no response from antibodies—the frontline guardians of the immune system which are trained to recognise an intruder.

Another battery of tests found that H7N9 remains vulnerable to Tamiflu and Relenza, the two main drugs to combat serious flu infection, the study said.

But it also pointed to two patients whose virus had signs of mutational resistance to these treatments.

The paper said "the first epidemic has subsided" but a potent threat remains.

"Together with the challenges in the available treatments for H7N9 infection caused by its clinical severity and emerging antiviral resistance, further unpredictable evolution and adaptation of the H7N9 virus and the lack of pre-existing immunity leave the human population at high risk," it said.

"The threats of the H7N9 virus with pandemic potential should not be underestimated and intensive surveillance must be undertaken."

H7N9 kills more than a third of hospitalised patients, The Lancet reported last month.

The fatality rate is lower than for H5N1 which has killed about 60 percent of hospitalised patients, but higher than for H1N1 "swine flu", a new virus that unleased a pandemic in 2009-10, for which there was a 21-percent death rate among people requiring hospitalisation.

According to the UN's World Health Organisation (WHO), the likely source of infection for H7N9 is exposure to fowl, such as in live poultry markets.

"Evidence does not support sustained human-to-human transmission," the agency said on its website.

Explore further: Only 14 China H7N9 patients left in hospital

More information: Paper: dx.doi.org/10.1038/nature12379

Related Stories

Only 14 China H7N9 patients left in hospital

June 10, 2013
Only 14 patients from China's H7N9 bird flu outbreak are still in hospital, national health authorities said in their latest update on the disease.

China reports another H7N9 bird flu death

June 27, 2013
Shanghai has reported another death from H7N9 bird flu, the local government said, bringing the total number of fatalities nationwide to at least 40.

H7N9 bird flu: Lancet study confirms poultry as source (Update)

April 25, 2013
Chinese researchers reporting in The Lancet on Thursday confirmed poultry as a source of H7N9 flu among humans but said they found no evidence of person-to-person transmission.

New estimates suggest that a third of H7N9 patients admitted to hospital have died

June 23, 2013
A group of researchers at the Chinese Center for Disease Control and Prevention, in Beijing, China and The University of Hong Kong, analysed data on hospital admissions related to H7N9, as well as using surveillance data ...

Confirmed cases of H7N9 bird flu drug resistance: study (Update)

May 28, 2013
Laboratory tests have revealed resistance in some H7N9 bird flu patients to the only available treatment, said virologists who unveiled "concerning" study results on Tuesday.

H7N9 bird flu spreads to central China's Hunan

April 27, 2013
China's deadly outbreak of H7N9 bird flu has spread to the central province of Hunan, local health authorities said Saturday, the third announcement in three days of a case in a new location.

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.